SPRR2D and cancer: Additionally, the GLMQL-MAS system highlighted the small proline-rich protein family (SPRR) including SPRR2B, SPRR2E, and SPRR2D, noted for their significant roles in cancer-related pathways and their potential as therapeutic targets.